CBD IN INDIA

India and CBD

Dr. Sikandar Sidhu has been working hard to get CBD into India. We are working with the local authorities to open a legal pathway for CBD into the Indian retail market.

Our partners, Star Cannabis India are the first Legal importer for CBD products into India. Star Cannabis India has been successful to get the CBD products for external use in India for online sales through India's first licensed online store that is selling CBD to Indian customers.

Star Cannabis India is also the first Indian company that has the ability to manufacture, distribute and sell CBD products in India and around the world. Through this collaboration, we plan on leading the charge of introducing legal CBD into the Indian retail market. We are also striving forward with our test run for Hemp cultivation in India.

Logo India Cbd Store.png

EXO CBD INDIA

Dr. Sikandar Sidhu has been working together with EXO CBD Los Angeles to create a B2B service in India for CBD products. With the legalization of CBD in India, we believe that businesses will need reliable B2B partners in India.

EXO CBD is USA's leading CBD manufacturer who hold over 100 patents for different products that we want to introduce into the Indian market. With a growing population of Indian consumer market for CBD products we want to register and launch these products into the Indian market.

We want to be the reliable One Stop Shop for all things CBD in India. With our goal of setting up manufacturing and cultivation in India to better capitalize on the growing domestic market, we look forward to creating partnerships globally.

EXO CBD India Logo.png
Contact us for Investor Opportunities in India

HEMP VS MARIJUANA

The most often widespread confusion that exists about Cannabis revolves around the differentiation between Hemp and Marijuana. These are both members of the same Cannabis family however their composition differs significantly.

THC is prepared from Marijuana where CBD is prepared from Hemp that contains less that 0.3% THC in them. However NANO CBD has no THC to a Billionth level that gets the claim of 0% THC. This is why Dr. Sidhu works with NANO CBD only which contains no THC in them.

For the legal push of CBD in India it is extremely important that we only use NANO CBD because even 0.3% of THC has a completely different schedule of classification and the workflow required.

WHY CBD IN INDIA?

Cannabis in India has been used since as early as 2000 BCE. In Indian society, common terms for cannabis preparations include charas (resin), ganja|maal|dum (flower), and bhang (seeds and leaves), with Indian drinks, such as, bhang lassi and bhang thandai, made from bhang, being one of the most common legal usages in India.

As of 2000, per the UNODC the "prevalence of usage" of cannabis in India was 3.2%. A 2019 study conducted by the All India Institutes of Medical Sciences reported that about 7.2 million Indians had consumed cannabis within the past year. According to the UNODC’s World Drug report 2016, the retail price of cannabis in India was US$0.10 per gram, the lowest of any country in the world

Cannabis sativa is one of the candidates for the identity of the plant that was used to prepare soma in Vedic period. Soma was an intoxicating ritual drink that has been highly praised in the Rigveda (c. 1700–1100 BCE).

congress-hemp-2.png
Bhang_eaters_before_two_huts_(6124556163

Bhang eaters from India c. 1790. Bhang is an edible preparation of cannabis native to the Indian subcontinent. It has been used in food and drink as early as 1000 BCE by Hindus in ancient India

FIRST STEPS TOWARDS A POSITIVE FUTURE OF CBD IN INDIA

In March 2015, Lok Sabha MP for Dhenkanal Tathagata Satpathy stated on a Reddit AMA that he supported the legalization of cannabis, and also admitted to having consumed the drug on several occasions when he was in college. He later repeated his comments on television and during interactions with the media. On 2 November 2016, Lok Sabha MP Dharamvir Gandhi announced that he had received clearance from Parliament to table a Private Member's Bill seeking to amend the NDPS Act to allow for the legalized, regulated, and medically supervised supply of "non-synthetic" intoxicants including cannabis and opium.

On 21 February 2017, Gujarat legalized bhang by removing it from the list of "intoxicating drugs" covered by section 23 of the Gujarat Prohibition Act.

On 12 December 2017, Viki Vaurora, the founder of the Great Legalization Movement India, penned an open letter to Prime Minister Narendra Modi and all members of Parliament advocating the urgent need to legalize the cultivation of cannabis and hemp for medical and industrial use. In February 2018, the Prime Minister's Office sent a notification to the Ministry of Health and Family Welfare directing the ministry to examine the potential benefits associated with cannabis and issue a response to the letter.

On July 10, 2018 Uttarakhand Government allowed the cultivation of Hemp in the state. Uttar Pradesh and Himachal also show potential steps towards legalization of Hemp.

In July 2019, the Delhi High Court agreed to hear a petition, filed by the Great Legalization Movement Trust, challenging the ban on cannabis. The public interest litigation argues that grouping cannabis with other chemical drugs under the NDPS Act is "arbitrary, unscientific and unreasonable".

USES OF CBD

congress-hemp-14.png
9157ec_b5834f2c72724853bcdc4ed8f5e5e5f1_
how-cbd-works-in-the-body-1-1024x771.png
  1. Seizure disorder (epilepsy). A specific cannabidiol product (Epidiolex, GW Pharmaceuticals) has been shown to reduce seizures in adults and children with various conditions that are linked with seizures. This product is a prescription drug for treating seizures caused by Dravet syndrome or Lennox-Gastaut syndrome. It has also been shown to reduce seizures in people with tuberous sclerosis complex, Sturge-Weber syndrome, febrile infection-related epilepsy syndrome (FIRES), and specific genetic disorders that cause epileptic encephalopathy. But it's not approved for treating these other types of seizures.

  2. Multiple sclerosis (MS). A prescription-only nasal spray product (Sativex, GW Pharmaceuticals) containing both 9-delta-tetrahydrocannabinol (THC) and cannabidiol has been shown to be effective for improving pain, muscle-tightness, and urination frequency in people with MS. This product is used in over 25 countries outside of the United States. But there is inconsistent evidence on the effectiveness of cannabidiol for symptoms of multiple sclerosis when it is used alone. Some early research suggests that using a cannabidiol spray under the tongue might improve pain and muscle tightness, but not muscle spasms, tiredness, bladder control, mobility, or well-being and quality of life in patients with MS.

  3. Bipolar disorder. Early reports show that taking cannabidiol does not improve manic episodes in people with bipolar disorders.

  4. A type of inflammatory bowel disease (Crohn disease). Early research shows that taking cannabidiol does not reduce disease activity in adults with Crohn disease.

  5. Diabetes. Early research shows that taking cannabidiol does not improve blood glucose levels, blood insulin levels, or HbA1c in adults with type 2 diabetes.

  6. An inherited brain disorder that affects movements, emotions, and thinking (Huntington disease). Early research shows that taking cannabidiol daily does not improve symptoms of Huntington's disease.

  7. Insomnia. Early research suggests that taking 160 mg of cannabidiol before bed improves sleep time in people with insomnia. However, lower doses do not have this effect. Cannabidiol also does not seem to help people fall asleep and might reduce the ability to recall dreams.

  8. Withdrawal from heroin, morphine, and other opioid drugs. Early research shows that taking cannabidiol for 3 days reduces cravings and anxiety in people with heroin use disorder that are not using heroin or any other opioid drugs.

  9. Parkinson disease. Some early research shows that taking cannabidiol daily for 4 weeks improves psychotic symptoms in people with Parkinson disease and psychosis.

  10. Schizophrenia. Research on the use of cannabidiol for psychotic symptoms in people with schizophrenia is conflicting. Some early research suggests that taking cannabidiol four times daily for 4 weeks improves psychotic symptoms and might be as effective as the antipsychotic medication amisulpride. However, other early research suggests that taking cannabidiol for 14 days is not beneficial. The conflicting results might be related to the cannabidiol dose used and duration of treatment.

  11. Quitting smoking. Early research suggests that inhaling cannabidiol with an inhaler for one week might reduce the number of cigarettes smoked by about 40% compared to baseline.

  12. A type of anxiety marked by fear in some or all social settings (social anxiety disorder). Some early research shows that taking cannabidiol 300 mg daily does not improve anxiety during public speaking in people with social anxiety disorder. However, other early research in people with social anxiety disorder suggests that taking a higher dose (400-600 mg) may improve anxiety associated with public speaking or medical imaging testing. Also, some research in people who do not have social anxiety disorder shows that taking cannabidiol 300 mg might reduce anxiety during public speaking.

  13. A movement disorder marked by involuntary muscle contractions (dystonia). Early research suggests that taking cannabidiol daily for 6 weeks might improve dystonia by 20% to 50% in some people. Higher quality research is needed to confirm this.

  14. A condition in which a transplant attacks the body (graft-versus-host disease or GVHD). Graft-versus-host disease is a complication that can occur after a bone marrow transplant. In people with this condition, donor cells attack the person's own cells. Early research shows that taking cannabidiol daily starting 7 days before bone marrow transplant and continuing for 30 days after transplant can extend the time it takes for a person to develop GVHD.

Hemp, a high-value crop, is ideal for a States where topology and acute water scarcity come in the way of growing conventional crops. Besides, destruction of crops by wild animals is quite rampant in which is not an issue with this crop.

Hemp, which can be harvested in three months, requires very little water and in places where water is abundant two crops can be grown, he said.

Master.jpg

CASH CROP OF THE FUTURE

5dae94eb19e05d001ed73c47.jpg

  1. Breeders are focused on developing high-quality cannabis seeds. Cultivators and dispensaries need to be able to rely on the fact that a breeder's seed will produce the correct strain of cannabis. Many breeders are also on the forefront of creating new strains and experimenting with plant traits. Much of this focus is on the effects of the strain on the end user, but breeders are also interested in creating more resilient plants with higher yields.

  2. Cultivators are the businesses that grow the cannabis plant itself. It's a relatively difficult sector to break into. Most state regulations require that cannabis be grown indoors under a clear set of circumstances, meaning cultivators need to lease or buy warehouse space and convert it to meet their needs.

  3. Cultivation requires a lot of energy from grow lights and climate control systems, and security must be top of mind. Each state has its own licensure process a cultivator must pass through before starting to grow. They tend to be arduous and require a business plan, clear financials, a floorplan of the facility and more.

  4. Some states require that cultivators be vertically integrated with dispensaries as well, meaning one operator must manage the full operation from growth to sale.

  5. Dispensaries are where most consumers encounter the product itself for the first time. Dispensaries, like cultivation facilities, typically go through a thorough application process to obtain licensure from the state. Because licenses are usually limited in number, the process can be highly competitive. It requires a strong foundation, a ready-made infrastructure, a vast network and, of course, money.

  6. Dispensaries have the added challenge of managing their cash. Because cannabis remains federally illegal, many banks won't work with cannabis companies. This creates problems for every business in the industry, but the retail environment of a dispensary becomes especially difficult to manage. Many dispensaries operate in an all-cash manner, although some ancillary businesses have launched to address this problem. 

  7. Extractors : Cannabis extractors take raw plant material and turn it into concentrates, such as oil. These concentrates are highly potent substances that emphasize the cannabinoids, or compounds unique to cannabis, like THC and CBD.

  8. Concentrates can either be consumed by end users directly in a vaporizer or sold to them for purposes like cooking cannabis-infused meals. However, many concentrates are sold to value-added manufacturers that use the extracted material to create new products like edibles. Extraction requires a significant upfront investment in the right machinery and demands an intimate knowledge of the various processes used to extract cannabinoids from the plant material.

  9. Manufacturers conduct the value-added processes that take cannabis flowers and concentrates and turn them into various products. For example, any edible product, such as cookies, brownies or gummy bears, was part of a manufacturing process to infuse the edible with cannabinoids. Like extraction, manufacturing requires upfront investment in the necessary facilities and machinery to produce manufactured products at scale. Like all plant-touching businesses, manufacturers must be acutely aware of their state's regulations and abide by them closely.

  10. Ancillary service providers :  Ancillary businesses are the wide range of companies providing B2B services to other businesses in the space. The great thing about starting an ancillary business in cannabis is it gives you an opportunity to pivot your existing skill set and experience into a young and rapidly expanding industry.

  11. Although the cannabis industry is now booming, it's still young. The entire U.S. cannabis market is estimated to be worth up to $55 billion, meaning the black market still accounts for about 80 percent of the industry's value.

  12. As more states legalize and the federal government debates following in their footsteps, that market share is likely to shift to the legal side. As the industry increases in value, cannabis companies will have more to spend on services.

  13. Think about what you're already good at and consider launching a cannabis-specific company providing that service. For example, digital marketers can specialize in marketing for cannabis businesses. The key is thoroughly researching cannabis and the industry, engaging in one of the many cannabis-specific trade associations or networking organizations, and establishing yourself as a thought leader in the space.

DON'T TAKE OUR WORD

TAKE A LOOK AT THE NUMBERS

Dr. Sikandar Sidhu has been working with Dreambird CBD for over 6 months to develop high quality CBD products that are designed for personal wellness. These products are carefully created using NANO CBD for everyday use for non medicinal purposes.

These products are aimed at the growing Personal Wellness and Health & Fitness market. Dreambird's products include CBD Beverage Enhancers & CBD Powder Packs containing 20 MG CBD per serving to create the perfect dose for a single use.

These products can be used as needed by the customers due to the unique propriety blend used. They can compliment any drink like Coffee, Tea, Soft drinks, Water etc. These can also be added to food to create unique blend with traditional recipes.

07-2019-TCR-cannabis-graphic-1-of-5-1.jp
chartoftheday_17550_projected_growth_cbd
5dae94eb19e05d001ed73c46.jpg
CBD_Estimates_DB.png
cannabidiol-cbd-market-size.png
Contact for Investor Opportunities in India

CBD IN USA

DREAMBIRD CBD

Dr. Sikandar Sidhu has been working with Dreambird CBD for over 6 months to develop high quality CBD products that are designed for personal wellness. These products are carefully created using NANO CBD for everyday use for non medicinal purposes.

These products are aimed at the growing Personal Wellness and Health & Fitness market. Dreambird's products include CBD Beverage Enhancers & CBD Powder Packs containing 20 MG CBD per serving to create the perfect dose for a single use.

These products can be used as needed by the customers due to the unique propriety blend used. They can compliment any drink like Coffee, Tea, Soft drinks, Water etc. These can also be added to food to create unique blend with traditional recipes.

DreamBird bottle HAZELNUT SINGLE.png
DreamBird bottle CITRUS SINGLE.png
DreamBird bottle original SINGLE.png

BUBBLES CBD

Bubbles CBD is a premium CBD lifestyle company that specializes in daily use products. Bubbles, as the name suggests is not a medicinal company. The brand encourages the incorporation of CBD into your daily routine with easy to use products that can replace your current in use products.

Dr. Sikandar Sidhu has opened this brand to educate and create a an easy to use options for those looking to benefits of long term CBD use. With our different proprietary blends, we give our customers a healthy alternative to using traditional methods prescribed at the moment.

Dr. Sidhu is currently working to get these products registered in India for retail as well as online sale. Our aim is to launch India's first ingest able CBD products for sale in India by the year 2021.

We are closer than ever to reaching out dream.

0f08106c-abc9-437a-b8f6-59aa80a7d192.gif
mockup_recover10.jpg
mockup_relax10.jpg
mockup_natural10.jpg
mockup_relax10.jpg